Sponsorship and Support: This webinar is sponsored by Primary Care Education Consortium, in collaboration with the Primary Care Metabolic Group. It is supported by educational grants from Novo Nordisk and Eli Lilly and Company.
Accreditation: The Southern Medical Association (SMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation: The Southern Medical Association designates this enduring activity for a maximum of 4.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Certificates of participation are provided to attendees not eligible for AMA PRA Category 1 CreditsTM. The term of approval is from February 27, 2026, to August 28, 2026.
Faculty Disclosure Information: SMA adheres to the conflict-of-interest policy of the ACCME and the AMA. It is the policy of SMA to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. All individuals in a position to control the content in our programs are expected to disclose any relationships they may have with commercial companies whose products or services may be mentioned so that participants may evaluate the objectivity of the presentations. In addition, any discussion of off-label, experimental, or investigational use of drugs or devices will be disclosed by the faculty. Only those participants who have no conflict of interest or who agree to an identified mitigation process prior to their participation were involved in the CME activity.
Dr. Brunton discloses that he serves as a consultant and speaker for Lilly and AstraZeneca, and as a consultant for Novo Nordisk and Sanofi. He also has stock options for Paracrine.
Dr. Kushner discloses that he serves as an advisor for Abbvie, Antag, Altimmune, Boehringer Ingelheim, Currax, Eli Lilly, Novo Nordisk, Structure and Weight Watchers. He also serves as a consultant for AstraZeneca.
Dr. Miller discloses that she is serves as an advisory and speaker for Abbott, Eli Lilly, Boehringer Ingelheim, Insulet, and Novo Nordisk. She also serves as a speaker for Bayer and Corcept.
Dr. Christopher Still discloses that he is a consultant and speaker for Novo Nordisk and Lilly; a consultant for Currax, Boehringer Ingelheim, and Regeneron; and is contracted for research with Ethicon Endosurgery.
Dr. Ryan discloses that she serves as an advisor for Abbvie, Altimmune, Amgen, AstraZeneca, Biohaven, Boehringer Ingelheim, Calibrate, Carmot/Roche, Cin Rx, Currax, Zealand, eMed, Epitomee, Structure Therapeutics, WW, Tenvie, Viking, Wondr Health, Fractyl, Gila, i20, Souffle Therapeutics, Source Bio, Lilly, Nestle, PPD, Scientific Intake, Pfizer, Protagonist, Novo Nordisk, Regeneron, and Sanofi. She also serves as a speaker for Lilly and Novo Nordisk, and on the Data Monitoring Committee for Rhythm, Lilly, and Cin Rx.
Joseph Nadglowski, faculty, Austin Ulrich, PharmD, medical writer and reviewer, and Nora Williams, PCEC COO, have no relevant financial disclosures to report.
All relevant financial relationships have been mitigated.
Learning Objectives: After viewing this webinar, participants should be able to
• Describe obesity as a chronic, treatable disease with significant health implications.
• Implement measures beyond BMI to assess and manage obesity.
• Develop patient-centered approaches to obesity care that include patients’ preferences and individual needs.
• Integrate guideline recommendations for initiating, monitoring, and optimizing pharmacologic obesity treatment.
• Design comprehensive, individualized treatment plans for patients with overweight or obesity, including addressing obesity-related complications.
Note that, while you may complete the webinars at your convenience, you will need to complete all five chapters to receive credit.
Chapter One: Disease/Lifestyle Interventions (90 minutes)
<INSERT WEBINAR HERE>
Chapter Two: Pharmacology (60 minutes)
<INSERT WEBINAR HERE>
Chapter Three: Is Bariatric Surgery Still Relevant? (30 minutes)
<INSERT WEBINAR HERE>
Chapter Four: Bias & Communication (45 minutes)
<INSERT WEBINAR HERE>
Chapter Five: Access & Affordability of Medications (60 minutes)
<INSERT WEBINAR HERE>
To receive your certificate after watching all five chapters of the webinar, click HERE to complete the evaluation survey.
Thanks for watching our webinar!
If you have any questions, please email Nora Williams at nwilliams@pceconsortium.org.